Hirschsprung disease (HSCR) is a complex developmental disorder characterised by the lack of enteric neurons in distal portions of the gut. Importantly, HSCR presents a dramatic sex bias with at least 4 times more males affected than females for reasons that are unknown. Genome-wide mapping studies of patients have failed to identify sex-linked genes associated with HSCR while experimental studies have largely overlooked the effects of sex.
Hirschsprung disease (HSCR) is a complex developmental disorder characterised by the lack of enteric neurons in distal portions of the gut. Importantly, HSCR presents a dramatic sex bias with at least 4 times more males affected than females for reasons that are unknown. Genome-wide mapping studies of patients have failed to identify sex-linked genes associated with HSCR while experimental studies have largely overlooked the effects of sex.
Here, we exploit several mouse models of HSCR, including Sox10LacZ/+, Ret 51/51 and Ret S697a/S697a, to investigate the sex bias. We identify a difference in phenotype severity at early postnatal stages in all the models, with males exhibiting greater extents of hypoganglionosis or aberrant ENS in the colon compared to females. At embryonic stage E14.5, Sox10LacZ/+ and Ret 51/51 guts showed no obvious differences in phenotype severity. This defines the critical period during which the sex bias may operate.
To identify sex-specific differences in gene expression we performed RNAseq analyses on populations of normal neural crest cell derivatives and mesenchymal cells isolated from Wnt1-cre;R26YFP E15.5 embryonic guts. Preliminary analyses suggest that males have higher levels of apoptosis in enteric neural crest cells, while females have increased levels of proliferation. Further transcriptomic analyses performed at additional embryonic stages as well as in our HSCR models will allow us to identify candidate genes and specific pathways that are upregulated or downregulated in males and females, causing males to be more affected.
To investigate whether these sex differences are due to sex-linked genes or sex hormones, we will also exploit the "four-core genotype model" to study our mutations of interest in XX and XY males and XX and XY females. In combination with our transcriptomic analyses, this provides groundwork to understand the sex-linked disease mechanisms leading to the sex bias of HSCR. doi:10.1016/j.mod.2017.04.023
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Crosstalk between Notch and FSH signaling, key to ovarian cancer progression Sakshi Gera, Rajan Dighe Iisc, Bangalore, India A growing body of scientific literature confirms an increased Notch signaling activity in ovarian carcinoma. Another key player known for ovarian cancer progression is the Follicle stimulating hormone (FSH). Sporadic reports propose that effect of FSH on Ovarian cancer development might be mediated via Notch signaling. The purpose of the current study is to understand the connection between FSH and Notch signaling in ovarian cancer progression.
There was a dose dependent increase in Notch signaling activity in response to FSH in the ovarian cancer cell line Ovcar-3. In these cells, there was a marginal increase in Notch signaling activity within 3 hrs of FSH (100mIU/ml) treatment, which increased to 4 fold after 36 hrs and remained constant thereafter. There was also an increase in Notch 3 receptor and the ligands Delta 1 (DLL1) and Delta 4 (DLL4), both at the transcripts and protein levels in response to FSH with concomitant increase in the Notch downstream gene HeyL transcript. Addition of exogenous DLL4 showed an additive effect of FSH on the Notch signaling activity in Ovcar-3 cells. These effects were abrogated in the presence of the antibody raised against the extracellular domain of FSH receptor. An ScFv specific for Notch3 NRR also inhibited FSH induced notch signaling in the Ovcar-3 cells. FSH also increased the proliferation of ovarian cancer cells, which was inhibited by FSHr and Notch antagonist. Ovcar-3 spheroids also showed an upregulated notch signaling in response to FSH. Also, FSH increased the aggregation of Ovcar3 cells in non adherent conditions to make bigger spheroids. Larger spheroids are known to have chemoresistance and known to play a role in metastasis. Further analysis showed an increase in the expression of STAT-3, a downstream target of FSH signaling, which is also a common transcript factor for Notch3, DLL1 and DLL4. Thus the current study shows the crosstalk between FSH and Notch signaling in the ovarian cancer cells, which seems to be an loop in ovarian cancer progression. Failure of neural tube closure during embryonic development can result in anencephaly (absence of brain) which is one of the most severe and common birth defects worldwide (5-10 cases in 10,000 live births). To better understand its aetiology and pathogenesis we selected families with recurrent anencephalic foetuses.
By whole-exome sequencing, we identified a recessive germline 21 bp in-frame deletion in the NUAK2 gene that segregated with the absence of brain in three foetuses born to consanguineous parents. NUAK2 (a.k.a SNARK) encodes a serine/threonine kinase, a member of the AMPK-related kinase family. In vitro phosphorylation assays demonstrated that the 7 amino-acid deletion in the NUAK2 kinase domain abrogated its kinase activity. Consistent with this being a null allele, a knockout of NUAK2 in mice also caused severe exencephaly (Ohmura et al., 2012) .
To further study the role of NUAK2 during neural tube morphogenesis, cerebral organoids were generated from patientderived induced pluripotent stem cells. Abnormal neural tube-like structures were observed in mutant mini-brains compared to control, indicating that NUAK2 is key to impart proper neuroepithelial architecture. SILAC pull-down and immunostainings in mini-brain suggest that NUAK2 regulates the actomyosin and tubulin networks via phosphorylation of multiple targets, forcing apical Abstracts S29
